Trastuzumab (Herceptin)

Trastuzumab (Herceptin) belongs to a group of drugs called monoclonal antibodies. It’s a targeted therapy (also called biological therapy).

Targeted therapies block the growth and spread of cancer. They target and interfere with processes in the cells that cause cancer to grow.

Trastuzumab is the generic (non-branded) name of the drug. Its current brand name is Herceptin.

Last reviewed: July 2016
Next planned review begins 2018

Let us know what you think

Please note that we cannot respond to comments. If you have any questions about breast cancer please contact the Helpline on 0808 800 6000.

Sign up for our newsletter